(Hypertension. 2000;36:62.)
© 2000 American Heart Association, Inc.
Scientific Contributions |
Hypertension in Black Patients
An Emerging Role of the Endothelin System in Salt-Sensitive Hypertension
From the Department of Surgery, Medical University of South Carolina, Charleston.
Correspondence to Dr Adviye Ergul, Medical University of South Carolina, Strom Thurmond Research Building, Suite 625, PO Box 250778, Charleston, SC 29425. E-mail ergula{at}musc.edu
Abstract—The prevalence of essential hypertension in blacks is much higher than that in whites. In addition, the pathogenesis of hypertension appears to be different in black patients. For example, black patients present with a salt-sensitive hypertension characterized by low renin levels. Racial differences in renal physiology and socioeconomic factors have been suggested as possible causes of this difference, but reasons for this difference remain unclear. Endothelial cells are important in the regulation of vascular tonus and homeostasis, in part through the secretion of vasoactive substances. One of these factors, endothelin-1 (ET-1), is a 21 amino acid residue peptide with potent vasopressor actions. In addition to its contractile effects, it has been shown to stimulate mitogenesis in a number of cell types. Moreover, ET-1 displays modulatory effects on the endocrine system, including stimulation of angiotensin II and aldosterone production and inhibition of antidiuretic hormone in the kidney. Recent data from several laboratories indicate that ET-1 is overexpressed in the vasculature in several salt-sensitive models of experimental hypertension. Moreover, circulating plasma ET-1 levels are significantly increased in black hypertensives compared with white hypertensives. Thus, the ET system might be particularly important in the development or maintenance of hypertension in this population.
Key Words: endothelin • hypertension, essential • blacks • sodium, dietary • race
This article has been cited by other articles:
 |
|
 |
|
  H. I. Cohn, Y. Xi, S. Pesant, D. M. Harris, T. Hyslop, B. Falkner, and A. D. Eckhart G Protein-Coupled Receptor Kinase 2 Expression and Activity Are Associated With Blood Pressure in Black Americans Hypertension, July 1, 2009; 54(1): 71 - 76. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. R. Mahapatra Catestatin is a novel endogenous peptide that regulates cardiac function and blood pressure Cardiovasc Res, December 1, 2008; 80(3): 330 - 338. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. J Epstein Efficacy and Safety of Darusentan: A Novel Endothelin Receptor Antagonist Ann. Pharmacother., July 1, 2008; 42(7): 1060 - 1069. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. McNamara, S. W. Tam, M. L. Sabolinski, P. Tobelmann, K. Janosko, A. L. Taylor, J. N. Cohn, A. M. Feldman, and M. Worcel Aldosterone Synthase Promoter Polymorphism Predicts Outcome in African Americans With Heart Failure: Results From the A-HeFT Trial J. Am. Coll. Cardiol., September 19, 2006; 48(6): 1277 - 1282. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Dai and J. J. Galligan Differential Trafficking and Desensitization of Human ETA and ETB Receptors Expressed in HEK 293 Cells. Experimental Biology and Medicine, June 1, 2006; 231(6): 746 - 751. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Duffy, E. S. Biegelsen, R. T. Eberhardt, D. F. Kahn, B. A. Kingwell, and J. A. Vita Low-Renin Hypertension With Relative Aldosterone Excess Is Associated With Impaired NO-Mediated Vasodilation Hypertension, October 1, 2005; 46(4): 707 - 713. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. D'Angelo, J. S. Pollock, and D. M. Pollock Endogenous endothelin attenuates the pressor response to acute environmental stress via the ETA receptor Am J Physiol Heart Circ Physiol, April 1, 2005; 288(4): H1829 - H1835. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. A. Elmarakby, E. D. Loomis, J. S. Pollock, and D. M. Pollock NADPH Oxidase Inhibition Attenuates Oxidative Stress but Not Hypertension Produced by Chronic ET-1 Hypertension, February 1, 2005; 45(2): 283 - 287. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. A. Young, W. J. Katon, M. Von Korff, G. E. Simon, E. H. B. Lin, P. S. Ciechanowski, T. Bush, M. Oliver, E. J. Ludman, and E. J. Boyko Racial and Ethnic Differences in Microalbuminuria Prevalence in a Diabetes Population: The Pathways Study J. Am. Soc. Nephrol., January 1, 2005; 16(1): 219 - 228. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Tycho Vuurmans, P. Boer, and H. A. Koomans Effects of endothelin-1 and endothelin-1-receptor blockade on renal function in humans Nephrol. Dial. Transplant., November 1, 2004; 19(11): 2742 - 2746. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Ergul, V. Portik-Dobos, A. D. Giulumian, M. M. Molero, and L. C. Fuchs Stress upregulates arterial matrix metalloproteinase expression and activity via endothelin A receptor activation Am J Physiol Heart Circ Physiol, November 1, 2003; 285(5): H2225 - H2232. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Houghton, D. S. Strogatz, M. T. Torosoff, V. E. Smith, S. A. Fein, P. A. Kuhner, E. F. Philbin, and A. A. Carr African Americans With LVH Demonstrate Depressed Sensitivity of the Coronary Microcirculation to Stimulated Relaxation Hypertension, September 1, 2003; 42(3): 269 - 276. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. J.L. Vuurmans, P. Boer, and H. A. Koomans Effects of Endothelin-1 and Endothelin-1 Receptor Blockade on Cardiac Output, Aortic Pressure, and Pulse Wave Velocity in Humans Hypertension, June 1, 2003; 41(6): 1253 - 1258. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Quaschning, S. Kocak, C. Bauer, H.-H. Neumayer, J. Galle, and B. Hocher Increase in nitric oxide bioavailability improves endothelial function in endothelin-1 transgenic mice Nephrol. Dial. Transplant., March 1, 2003; 18(3): 479 - 483. [Abstract] [Full Text] [PDF]
|
|